Hudson Bay Capital Management LP Janux Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 30,000 shares of JANX stock, worth $960,299. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,000
Previous 123,658
75.74%
Holding current value
$960,299
Previous $5.62 Million
71.41%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
228Shares Held
55.1MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$332 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$114 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$113 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$98 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$75 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.33B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...